Biofrontera AG Stock News

Biofrontera Inc. (Nasdaq: BFRI) is a biopharmaceutical company providing specialty dermatology therapies and services in the United States. Founded in March 2015, the company has a solid portfolio of pharmaceutical [] The post Biofrontera sees TAM of $4 Bln for lead product Ameluz: CEO Erica Monaco first appeared on AlphaStreet .

InvestorPlace - Stock Market News, Stock Advice & Trading Tips BFRI stock is an imperfect investment as Biofrontera isn''t currently profitable, but a new patent could provide a significant revenue source. The post $20 Price Prediction Is Ambitious but Possible for Biofrontera appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2 Says Buy THIS Now Man Who Called Black Monday: Prepare Now. #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First

BFRI stock is an imperfect investment as Biofrontera isn't currently profitable, but a new patent could provide a significant revenue source. The post $20 Price Prediction Is Ambitious but Possible fo

Biofronteras (NASDAQ:BFRI) quiet period is set to expire on Wednesday, December 8th. Biofrontera had issued 3,600,000 shares in its public offering on October 29th. The total size of the offering was $18,000,000 based on an initial share price of $5.00. During Biofronteras quiet period, underwriters and any insiders involved in the IPO are restricted from []

Biofronteras (NASDAQ:BFRI) quiet period is set to expire on Wednesday, December 8th. Biofrontera had issued 3,600,000 shares in its IPO on October 29th. The total size of the offering was $18,000,000 based on an initial share price of $5.00. During Biofronteras quiet period, insiders and any underwriters that worked on the IPO are prevented from []

Biofrontera (BFRI) stock is getting a boost on Thursday thanks to an update from the United States Patent and Trademark Office.

The stock price of Biofrontera Inc (NASDAQ: BFRI) increased by over 27% during intraday trading today. This is why it happened.

The United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Biofrontera Inc (NASDAQ: BFRI) titled "Illumination for Photodynamic Therapy." The patent covers pain-red

Biofrontera (BFRI) stock is getting a boost on Thursday thanks to an update from the United States Patent and Trademark Office. The post BFRI Stock: The News That Has Biofrontera Shares Bounding Highe

In 2018, DUSA Pharmaceuticals had filed a suit at the US District Court of Massachusetts against Biofrontera alleging "misappropriation of trade secrets, tortious interference of contract and unfair trade practices" The post Sun Pharma arm settles case with Biofrontera, to get $22.5 million appeared first on Express Pharma .

DUSA has reached a settlement with Biofrontera resolving the Litigation.